The present invention relates to novel atropisomers of 2-(aryl or heteroaryl)-3-aryl-4(3H)-quinazolinones of the formula I, and their pharmaceutically acceptable salts, and pharmaceutical compositions and methods of treating neurodegenerative and CNS-trauma related conditions.
本发明涉及公式I的新型2-(芳基或杂环芳基)-3-芳基-4(3H)-
喹唑啉酮的异构体,以及它们的药学上可接受的盐、制药组合物和治疗神经退行性和中枢神经系统创伤相关疾病的方法。